Table 8.
Interactions of apigenin and liquiritin with delta and delta plus variants of SARS-CoV-2
| Phytocompound/ drug | Delta | Delta plus | ||||
|---|---|---|---|---|---|---|
| Binding energy | H-bonding | Hydrophobic interactions | Binding energy | H-bonding | Hydrophobic interactions | |
| Apigenin | − 7 | 2Arg1012 | Thr959, Ala956, Tyr1005, Leu960, Ser1001, Gln963, Thr1004, Gln1008, Gln952, Gln955 | − 7.1 | - | Thr 959, Gln 1008, Gln 952, Gln 955, Ala 956, Arg 1012, Tyr 1005, Leu 960, Ser 1001, Gln 963, Thr 1004 |
| Liquiritin | − 7.3 | 5Thr300, Ser50, Asn315, Arg317, Gln626 | Cys299, Ala290, Cys289, Glu296, Lys302, Thr628, Thr272, Ser314, Trp631, Gln319 | − 7.3 | Gln626, Leu627, Ser314, Thr300, Thr272, Ser50 | Arg271, Cys299, Ala290, Thr272, Thr628, Pro629, Glu296, Lys302, Cys289 |